The DOI matches its Crossref record; 185 of the 187 references it cites were found in a registry or an index.
Moving towards personalized treatments of immune-related adverse events
Abstract
The enhancement of immune responses upon treatment with immune checkpoint inhibitors can have the desired outcome of reinvigorating antitumour immune surveillance, but often at the expense of immune-related adverse events (irAEs). This novel disease entity often prompts comparisons with, and extrapolation of treatment approaches from, primary autoimmune disorders. Accordingly, current treatment guidelines for irAEs make generic recommendations adapted from the literature describing primary autoimmune diseases, without taking into consideration the substantial disparity of the immunohistopathological findings within each organ affected by an irAE. The treatment modalities themselves are complex and have many potential drawbacks, such as serious and rarely fatal infections, drug toxicities overlapping with irAEs and the risk of compromising cancer immune surveillance. Herein, we provide an overview of key cellular and soluble immunological factors mediating irAEs and propose a model integrating this knowledge with the immunohistopathological findings of the affected organs for a personalized decision-making process for each patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although proving to be clinically effective in enhancing T-cell-mediated antitumor responses”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [168]
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Self-citationRole of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Brahmer, J. R., Lacchetti, C., Schneider, B. J., Atkins, M. B., Brassil, K. J., Caterino, J. M., Chau, I., Ernstoff, M. S., Gardner, J. M., Ginex, P., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6385 · Cited by 3,713
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature reviews. Immunology · doi:10.1038/nri1604 · Cited by 3,631
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488
Self-citationMutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Zaretsky, J. M., Garcia-Diaz, A., Shin, D. S., Escuin-Ordinas, H., Hugo, W., Hu-Lieskovan, S., Torrejon, D. Y., Abril-Rodriguez, G., Sandoval, S., Barthly, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604958 · Cited by 3,237
Cited by
Sorted by citations
Items 301–352 of 352
Unlocking the Code of Innovation: TRIZ Theory’s Blueprint for Precision Medicine Breakthroughs
Schmidt, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-77302-0_1
A Data-Driven Approach to Predicting and Visualizing Disease Progression in Hospitalized Patients
Jana, S., Dasgupta, T., & Sinha, M. (2025) · ACM International Conference on Intelligent User Interfaces (IUI) · doi:10.1145/3708557.3716327
Nebenwirkungen erkennen und managen
Bröckelmann, P. J., & Hassel, J. C. (2025) · Deutsche Dermatologie · doi:10.1007/s15011-025-6942-0
Deng, K.-F., Zhang, L., Li, L., & Fei, S. (2025) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v33.i7.513
Hao, W., Wang, Y., Zhang, J., & Cai, W. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500075
Immune Checkpoint Inhibitors and Myocarditis: Clinical Impact and Underlying Mechanisms
Moradi, A., Nada Muhamed, S. A. I. D., Khoshniyat, S., Ramey, K., Longobardi, S. A., & Subbiondo, R. J. (2025) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-90598-8_15
Diagnosis and Management of Toxicities Associated with Immunotherapy in Cancer
de Pinho, I. S., Araújo, J., Mansinho, A., de Sousa, R. T., & Costa, L. (2025) · Springer eBooks · doi:10.1007/978-3-032-00775-9_341
Gastrointestinal Side Effects of Anticancer Therapy
Uranga, J. A., Nurgali, K., & Abalo, R. (2025) · Springer eBooks · doi:10.1007/978-3-032-00775-9_343
Ya, Z., Wu, H., Jia, W., Li, Y., Zhu, M., Zhang, L., Zong, Y., Guo, S., Bouakaz, A., & Wan, M. (2025) · Research Square · doi:10.21203/rs.3.rs-7968444/v1
Meng, C., Qiao, C., Hao, Q., Shi, J., Lou, C., Song, J., Wang, L., Yang, J., Ma, X., Kang, H., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202516391
Wei, L., Yan, W., Zhang, K., Gao, F., Li, Z., Pan, R., Zhang, Z., & Wang, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1691259
Genta, S., Lajkosz, K., Yee, N., Spiliopoulou, P., Heirali, A., Hansen, A. R., Siu, L. L., Saibil, S., Stayner, L.-A., Yanekina, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630134
Genta, S., Lajkosz, K., Yee, N., Spiliopoulou, P., Heirali, A., Hansen, A. R., Siu, L. L., Saibil, S., Stayner, L.-A., Yanekina, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630104
Genta, S., Lajkosz, K., Yee, N., Spiliopoulou, P., Heirali, A., Hansen, A. R., Siu, L. L., Saibil, S., Stayner, L.-A., Yanekina, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630125
Genta, S., Lajkosz, K., Yee, N., Spiliopoulou, P., Heirali, A., Hansen, A. R., Siu, L. L., Saibil, S., Stayner, L.-A., Yanekina, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630128
Genta, S., Lajkosz, K., Yee, N., Spiliopoulou, P., Heirali, A., Hansen, A. R., Siu, L. L., Saibil, S., Stayner, L.-A., Yanekina, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630137
Genta, S., Lajkosz, K., Yee, N., Spiliopoulou, P., Heirali, A., Hansen, A. R., Siu, L. L., Saibil, S., Stayner, L.-A., Yanekina, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630110
Chen, P., Zhu, J., Xu, Y., Huang, Q., Su, J., Gao, Z., & Feng, M. (2023) · Figshare · doi:10.6084/m9.figshare.22679521
Genta, S., Lajkosz, K., Yee, N., Spiliopoulou, P., Heirali, A., Hansen, A. R., Siu, L. L., Saibil, S., Stayner, L.-A., Yanekina, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630116
Genta, S., Lajkosz, K., Yee, N., Spiliopoulou, P., Heirali, A., Hansen, A. R., Siu, L. L., Saibil, S., Stayner, L.-A., Yanekina, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630131
Chen, P., Zhu, J., Xu, Y., Huang, Q., Su, J., Gao, Z., & Feng, M. (2023) · Figshare · doi:10.6084/m9.figshare.22679524
Genta, S., Lajkosz, K., Yee, N., Spiliopoulou, P., Heirali, A., Hansen, A. R., Siu, L. L., Saibil, S., Stayner, L.-A., Yanekina, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630140
Genta, S., Lajkosz, K., Yee, N., Spiliopoulou, P., Heirali, A., Hansen, A. R., Siu, L. L., Saibil, S., Stayner, L.-A., Yanekina, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630107
Genta, S., Lajkosz, K., Yee, N., Spiliopoulou, P., Heirali, A., Hansen, A. R., Siu, L. L., Saibil, S., Stayner, L.-A., Yanekina, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630119
Genta, S., Lajkosz, K., Yee, N., Spiliopoulou, P., Heirali, A., Hansen, A. R., Siu, L. L., Saibil, S., Stayner, L.-A., Yanekina, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26630122
Mechanisms of Immunological Toxicity in Cancer Immunotherapy with Checkpoint Inhibitors
Polaczek, M. M., & Piotr, R. (2025) · Springer eBooks · doi:10.1007/978-3-032-00765-0_360
Li, Y., Li, Z., & Lingyu, C. (2025) · Cancer Investigation · doi:10.1080/07357907.2025.2599376
Macrophage-mediated delivery of microcapsules for enhanced photodynamic therapy of colon cancer
Terentyeva, D. A., Kozyreva, Z. V., Gusliakova, О. I., Demina, P. A., Kosov, A. D., Sain, A. Y., Abdurashitov, A. S., Proshin, P. I., German, S. V., Bratashov, D. N., et al. (2026) · Light Advanced Manufacturing · doi:10.37188/lam.2026.002
Su, F., Zhang, X.-L., Du, Y., Li, W., & Zhao, J. (2026) · Heliyon · doi:10.1016/j.heliyon.2026.e44598
Anquetil, C. (2021) · theses.fr (ABES) · doi:10.70675/dce475d2z4b83z4647z85aczea2eb971762b
Cancers associés au VIH : immunogénomique, immunogénicité et immunothérapie
Abbar, B. (2024) · theses.fr (ABES) · doi:10.70675/4f30d250zc7b8z462ez9893z38a97714c288
Matsui, K., Miyawaki, Y., Suzuki, Y., Furube, T., Yoshizawa, M., Toriumi, T., Ebara, G., Sato, H., & Sakuramoto, S. (2026) · Diseases of the Esophagus · doi:10.1093/dote/doag036
Baggi, A., Smussi, D., Lorini, L., Stucchi, E., Zamparini, M., Bettini, D. L., Alessandrini, N., Capelli, C., Azzolini, J., Tovazzi, V., et al. (2026) · Discover Oncology · doi:10.1007/s12672-026-05002-3
Zarańska, K., Kamińska‐Winciorek, G., Cortez, A. J., Wąsik, G., & Gajda, M. (2026) · Dermatology and Therapy · doi:10.1007/s13555-026-01780-4
Nishida, S., Shiroyama, T., Naito, Y., & Kumanogoh, A. (2026) · Immunological Medicine · doi:10.1080/25785826.2026.2674327
Huang, W.-T., Zhang, B.-B., & Zhao, J.-N. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.120350
Trösch, A., Zahn, C. A., Cazzaniga, S., Özdemir, B. C., Feldmeyer, L., & Benzaquen, M. (. (2026) · JAAD International · doi:10.1016/j.jdin.2026.05.023
The rise of sono-immunotherapy in Glioblastoma therapy
Feng, Y., Yang, Z., Feng, R., & Hai, Z. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.100861
Lymph node-targeted mRNA delivery of fine-tuned peptide-nanocomplexes for SARS-CoV-2 Vaccination
Jeong, H., Yoon, G., Lee, D. W., 유한상, Kim, Y. B., Kim, N., Choi, J., Shin, E., Kim, H., Jeong, H.-K., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124438
Zhang, Z., Gao, T., Li, L., Tan, X., & Zeng, P. (2026) · Hospital Pharmacy · doi:10.1177/00185787261463742
Green Biopolymer-Based Nanocarriers for Precision Cancer Therapeutics
Zahid, A., Afzal, A., Sulman, A., Naeem, M. S., Saeed, M. Y., mumtaz, F., Afzal, A., Shafaqat, M., Waheed, H., & Nawab, H. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-9848-8.ch004
Cao, Y., Zhao, C., Liang, Y., Li, X., Zhang, Z., Yang, Q., & Shao, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1894437
Liu, W., Tang, H. J., Li, N., Qiu, W., Li, X., & Zhao, L. (2026) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359261476860
Immune Checkpoint Inhibitors: Mechanisms and Emerging Challenges
Gill, G. S., Karmakar, S., & Goswami, S. (2026) · Springer eBooks · doi:10.1007/978-981-92-0477-9_22
Li, C., Li, M., Wu, X., Wu, X., Gao, H., Zhong, X., Yang, X., Hao, F., Li, C., & Wang, Q. (2026) · Biomaterials Science · doi:10.1039/d6bm00678g
Mukherjee, A. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.07.007
Management of Neonatal Cardiac and Hematologic Emergencies
Patel, K. R. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016129
Peeters, E., van Genugten, E. A. J., Stormezand, G. N., Schmiedehausen, K., Margolin, K. A., Postow, M. A., Heskamp, S., Herpen, C. M. L., Westdorp, H., & Aarntzen, E. H. J. G. (2026) · Research Square · doi:10.21203/rs.3.rs-10831511/v1
Shen, F., Fan, S., 王燕燕, Xu, Y., & Guo, W. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1937378
Jiang, L., Wang, J., Yang, X., Huang, T., & Zhou, H. (2026) · Medicine · doi:10.1097/md.0000000000051069
Dong, L., Zhang, L., Song, L., Qu, C., Wang, X., Xiao, S., Tian, M., Wang, P., Zhi, H., Zhao, Y., et al. (2026) · iScience · doi:10.1016/j.isci.2026.118063
Metadata
- Authors
- Esfahani, K., Elkrief, A., Calabrese, C., Lapointe, R., Hudson, M., Routy, B., Miller, W. H., & Calabrese, L.
- Affiliations
- McGill University (CA)
- Cleveland Clinic (US)
- Centre Hospitalier de l’Université de Montréal (CA)
- Corresponding author
- Esfahani, Khashayar
- ORCID
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2020-04-03
- Volume
- 17
- Issue
- 8
- Pages
- 504-515
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W3015154527
- Cited by
- 351
- References
- 187
- Citations by year
- 2026: 39 · 2025: 60 · 2024: 65 · 2023: 56 · 2022: 59 · 2021: 51 · 2020: 20
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- immune-related adverse events, immune checkpoint inhibitors, personalized treatment, immunohistopathology, immune reconstitution, tumor surveillance, autoimmune disease management, immunopathology
- MeSH terms
- Antineoplastic Agents, Immunological, Humans, Immunologic Factors, Immunologic Surveillance, Immunotherapy, Neoplasms, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
